The process of donating convalescent plasma includes the following steps:
Full Answer
The blood from people who recover from COVID-19 contains substances called antibodies, which are capable of fighting the virus that causes the illness. For some other diseases caused by respiratory viruses, giving people the liquid portion of blood that contains these antibodies, called plasma, obtained from those who have recovered from the virus, may lead to more rapid improvement of the disease. Patients with COVID-19 may improve faster if they receive plasma from those who have recovered from COVID-19, because it may have the ability to fight the virus that causes COVID-19.
Someone who has symptoms of COVID-19, including fever, cough, and shortness of breath, is not healthy enough to donate blood. Standard screening processes already in place will mean that someone with these symptoms will not be allowed to donate.
Yes, individuals who receive a nonreplicating, inactivated or mRNA-based COVID-19 vaccine can donate blood without a waiting period.
Blood donors must be healthy and feel well on the day of donation. Routine blood donor screening measures that are already in place should prevent individuals with respiratory infections from donating blood. For example, blood donors must be in good health and have a normal temperature on the day of donation.
Those who do get infected with mild-to-moderate COVID-19 will likely remain infectious no longer than 10 days after symptoms begin. Individuals with severe-to-critical illness stemming from a COVID infection likely aren't infectious 20 days after symptoms first began.
Research shows that people continue to shed virus that can be cultured in a laboratory — a good test of the potential to pass along the virus — for about eight days on average after testing positive.
Some people with COVID-19 develop abnormal blood clots, including in the smallest blood vessels. The clots may also form in multiple places in the body, including in the lungs. This unusual clotting may cause different complications, including organ damage, heart attack and stroke.
At this time, the FDA does not recommend using laboratory tests to screen blood. Someone who has symptoms of COVID-19, including fever, cough, and shortness of breath, is not healthy enough to donate blood.Standard screening processes already in place will mean that someone with these symptoms will not be allowed to donate.
Moderna, Pfizer begin omicron booster roll out The shots — also known as bivalent vaccines —are designed to target both the original coronavirus strain and the currently circulating omicron subvariants BA.4 and BA.5.
Vitamin D plays a role in the body's immune system and is known to enhance the function of immune cells. In this case, Vitamin D inhibits some of the inflammation that can make COVID-19 more severe.
Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies that can restore, enhance or mimic the immune system's attack on cells. Monoclonal antibodies for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus.
A healthy immune system can help your body ward off illnesses like colds, flu and COVID-19.
At this time, the FDA does not recommend using laboratory tests to screen blood. Someone who has symptoms of COVID-19, including fever, cough, and shortness of breath, is not healthy enough to donate blood.Standard screening processes already in place will mean that someone with these symptoms will not be allowed to donate.
Any time you catch a virus and recover from the illness, you retain antibodies. These antibodies help your body fight off future infections so that you either don't get sick or have milder symptoms.
COVID-19 is a disease caused by SARS-CoV-2 that can trigger what doctors call a respiratory tract infection. It can affect your upper respiratory tract (sinuses, nose, and throat) or lower respiratory tract (windpipe and lungs).
Vitamin D plays a role in the body's immune system and is known to enhance the function of immune cells. In this case, Vitamin D inhibits some of the inflammation that can make COVID-19 more severe.
To be eligible to donate convalescent plasma, the donor must have a prior, verified diagnosis of COVID-19, be symptom free, be at least 17 years old and weigh at least 110 lbs. Additional weight requirements apply for donors age 18 or younger.
The American Red Cross has partnered with Creative Testing Solutions to help the nation’s screening efforts for COVID-19 through antibody testing. The Red Cross’ screening efforts enable the distribution of convalescent plasma to ensure patients have access to a lifesaving treatment during this difficult time.
Red Cross antibody tests will also be helpful to identify individuals who have COVID-19 antibodies and may qualify to be convalescent plasma donors for future donations.
All blood donations are tested for multiple infectious diseases before being released for clinical practice. To further ensure the health and safety of our community, staff and donors must undergo temperature checks before they are permitted to participate in a drive.
The Red Cross is committed to keeping you safe during donation. Each blood drive or donation center follows the highest standards of safety and infection control. No one is permitted to enter a blood drive or donation center without an approved mask or face covering.
After a donation of blood or platelets, donors can log into the Blood Donor App to view a record of their vitals taken during pre-donation screening as well as the results of the antibody test. The following are the different types of results:
A single plasma donation may help treat up to three patients, according to the Red Cross.
In most cases, plasma donors are required to be at least 18 years old and weigh at least 110 pounds (though some centers allow people as young as 16 to donate). They must have gotten a clinical COVID-19 diagnosis and be symptom-free for at least two weeks.
At a donation center, donors are generally asked to provide a government-issued ID as well as evidence of their previous COVID-19 infection: usually a positive laboratory test, though some locations will accept antibody tests or clinical diagnoses. Some local centers may ask for a social security number, proof of local residency, or US visa for foreign nationals.
From there, donors go through a screening exam to check their body temperature, blood pressure, and pulse. If these readings are normal, they'll be taken to a bed, where their blood is then drawn through an IV.
That demand is expected to increase now that convalescent plasma has been approved for emergency use by the FDA. Already, several organizations have banded together to encourage donations: In May, a coalition of medical institutions, drug companies, nonprofits, and COVID-19 survivors launched "The Fight Is In Us," a campaign to get more recovered coronavirus patients to donate blood.
Demand for convalescent plasma is likely to keep rising now that the FDA has approved the treatment for emergency use.
If you've had COVID-19 and recovered, you can donate blood to sick patients — a therapy known as convalescent plasma. The FDA issued an emergency authorization for the treatment on Sunday, which allows doctors to administer the transfusions to hospitalized patients with COVID-19.